Collegium Pharmaceutical Inc (COLL) - Financial and Strategic SWOT Analysis Review

  • ID: 4284734
  • SWOT Analysis
  • 44 pages
  • GlobalData
  • Collegium Pharmaceutical Inc
1 of 5

FEATURED COMPANIES

  • Acura Pharmaceuticals Inc
  • Elite Pharmaceuticals Inc
  • KemPharm Inc
  • Pain Therapeutics Inc
  • Shionogi Inc
  • MORE
Collegium Pharmaceutical Inc (COLL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Collegium Pharmaceutical Inc (Collegium) is a healthcare products provider that develops chronic pain and oral drug delivery solutions. The company's lead candidate, Xtampza ER, is an abuse-deterrent, extended-release, oral formulation of oxycodone that uses DETERx technology for the long-term continuous management of pain. It offers fast track designation from FDA for Xtampza ER in pain management. The company's other pipeline products comprise Xtampza, Nucynta ER, Nucynta IR, COL-172, COL-195, COL-196, and COL-171. It collaborates with organizations for product licensing, and technology development opportunities. Collegium is headquartered in Canton, Massachusetts, the US.

Collegium Pharmaceutical Inc Key Recent Developments

Jun 04, 2018: Collegium Promotes Joseph Ciaffoni To Chief Executive Officer
May 09, 2018: Collegium Reports First Quarter Financial Results and Provides Corporate Update 2018
Mar 19, 2018: Collegium Appoints Shirley Kuhlmann As General Counsel
Mar 07, 2018: Collegium Reports Fourth Quarter Financial Results and Provides Corporate Update 2017
Nov 08, 2017: Collegium Announcers Third Quarter Financial Results and Provides Corporate Update

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Acura Pharmaceuticals Inc
  • Elite Pharmaceuticals Inc
  • KemPharm Inc
  • Pain Therapeutics Inc
  • Shionogi Inc
  • MORE
Section 1 - About the Company
  • Collegium Pharmaceutical Inc - Key Facts
  • Collegium Pharmaceutical Inc - Key Employees
  • Collegium Pharmaceutical Inc - Major Products and Services
  • Collegium Pharmaceutical Inc - History
  • Collegium Pharmaceutical Inc - Company Statement
  • Collegium Pharmaceutical Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Collegium Pharmaceutical Inc - Business Description
  • R&D Overview
  • Collegium Pharmaceutical Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Collegium Pharmaceutical Inc - Strengths
  • Collegium Pharmaceutical Inc - Weaknesses
  • Collegium Pharmaceutical Inc - Opportunities
  • Collegium Pharmaceutical Inc - Threats
  • Collegium Pharmaceutical Inc - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Collegium Pharmaceutical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • Collegium Pharmaceutical Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
  • Collegium Pharmaceutical Inc, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • May 09, 2018: Collegium Reports First Quarter Financial Results and Provides Corporate Update 2018
  • Mar 07, 2018: Collegium Reports Fourth Quarter Financial Results and Provides Corporate Update 2017
  • Nov 08, 2017: Collegium Announcers Third Quarter Financial Results and Provides Corporate Update
  • Aug 09, 2017: Collegium Reports Second Quarter Financial Results and Provides Corporate Update
  • May 30, 2017: Collegium Announces the Appointment of Joseph Ciaffoni as Chief Operating Officer
  • May 10, 2017: Collegium Reports 2017 First Quarter Financial Results and Provides Corporate Update
  • Apr 04, 2017: Collegium Announces Appointment of Steven Passik, PhD, as Vice President, Scientific Affairs, Education and Policy
  • Mar 09, 2017: Collegium Reports Fourth Quarter Financial Results and Provides Corporate Update
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
List of Tables
  • Collegium Pharmaceutical Inc, Key Facts
  • Collegium Pharmaceutical Inc, Key Employees
  • Collegium Pharmaceutical Inc, Major Products and Services
  • Collegium Pharmaceutical Inc, History
  • Collegium Pharmaceutical Inc, Subsidiaries
  • Collegium Pharmaceutical Inc, Key Competitors
  • Collegium Pharmaceutical Inc, Ratios based on current share price
  • Collegium Pharmaceutical Inc, Annual Ratios
  • Collegium Pharmaceutical Inc, Annual Ratios
  • Collegium Pharmaceutical Inc, Annual Ratios
  • Collegium Pharmaceutical Inc, Interim Ratios
  • Collegium Pharmaceutical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • Collegium Pharmaceutical Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
  • Collegium Pharmaceutical Inc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Collegium Pharmaceutical Inc, Performance Chart (2013 - 2017)
  • Collegium Pharmaceutical Inc, Ratio Charts
  • Collegium Pharmaceutical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • Collegium Pharmaceutical Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Elite Pharmaceuticals Inc
  • Acura Pharmaceuticals Inc
  • Pain Therapeutics Inc
  • Shionogi Inc
  • KemPharm Inc
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll